IGF1 and Alzheimer disease: The dichotomy of results from both included and omitted studies of serum IGF-1 in AD has led some researchers to measure other aspects of the IGF-1 pathway, including CSF IGF-1, CSF/serum IGF-1 ratio, and IGFBP-3 levels.